Skip to main content

Qube Research & Technologies Ltd

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$25,751,854
+$10,253,506 QoQ
Shares Held
498,198
+59.8% QoQ
Ownership
0.858%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $391,792,991 across 21 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 SUPN
Supernus Pharmaceuticals, Inc.
This page
498,198 $25,751,854

All Filings in SUPN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $25,751,854 498,198
2025-12-31 $15,498,348 311,838
2025-09-30 $5,931,838 124,123
2025-06-30 $7,240,459 229,710
2025-03-31 $3,212,054 98,078
2024-12-31 $2,354,377 65,110
2024-09-30 $3,148,057 100,964
2024-06-30 $4,284,600 160,172
2024-03-31 $327,558 9,603
2023-12-31 $2,729,765 94,325
2023-06-30 $1,783,099 59,318
2023-03-31 $1,678,390 46,326
2022-12-31 $1,147,682 32,175
2022-09-30 $520,240 15,369
2021-12-31 $1,509,030 51,750
2020-06-30 $248,757 10,474
2020-03-31 $192,475 10,699